The IMBG Test for Evaluating the Pharmacodynamic Response to Immunosuppressive Therapy in Kidney Transplant Patients: Current Evidence and Future Applications

The IMBG Test for Evaluating the Pharmacodynamic Response to Immunosuppressive Therapy in Kidney Transplant Patients: Current Evidence and Future Applications

Immunosuppressive drugs are widely used to prevent rejection after kidney transplantation. However, the pharmacological response to a given immunosuppressant can vary markedly between individuals, with some showing poor treatment responses and/or experiencing serious side effects. There is an unmet...

Full description

Bibliographic Details
Main Authors:	Julio Pascual, Marta Crespo, Jose Portoles, Carlos Jimenez, Alvaro Ortega-Carrion, Teresa Diez, Isabel Portero
Format:	Article
Language:	English
Published:	MDPI AG 2023-03-01
Series:	International Journal of Molecular Sciences
Subjects:	transplant rejection immunosuppressive therapy infection cellular pharmacodynamics immune cell assay
Online Access:	https://www.mdpi.com/1422-0067/24/6/5201

Similar Items

The Immunobiogram, a Novel In Vitro Assay to Evaluate Treatment Resistance in Patients Receiving Immunosuppressive Therapy
by: Jose Maria Portoles, et al.
Published: (2021-01-01)

Immunosuppression for postcardiac transplant patients
by: Dhara Singh
Published: (2018-01-01)

Pharmacokinetic/pharmacodynamic relationships of FTY720 in kidney transplant recipients
by: S.I. Park, et al.
Published: (2005-05-01)

Immunosuppression in lung transplantation: Changing perspectives
by: Unmil Shah, et al.
Published: (2021-01-01)

Immunosuppression with prolonged-release tacrolimus in kidney or liver transplantation in India
by: Dinesh Khullar, et al.
Published: (2017-01-01)

Immunosuppression and Liver Transplantation
by: Jan Lerut, et al.
Published: (2023-02-01)

Implantable Immunosuppressant Delivery to Prevent Rejection in Transplantation
by: Madonna Rica Anggelia, et al.
Published: (2022-01-01)

Immunosuppressive drugs and major complications in pediatric renal transplantation
by: Guerrero-Tinoco, Gustavo Adolfo, et al.
Published: (2017-01-01)

New immunosuppressive drugs in heart transplantation
by: Costanzo Maria Rosa
Published: (2001-02-01)

Impact of Infection-Related Immunosuppressant Reduction on Kidney Transplant Outcomes: A Retrospective Study Considering the Temporal Dynamics of Immunosuppressive Requirements
by: Bo Yang, et al.
Published: (2023-11-01)

Low-dose induction immunosuppression in deceased donor kidney transplantation during coronavirus disease pandemic - A multicentric prospective observational study
by: Jacob George, et al.
Published: (2021-01-01)

A Mathematical Model for Cisplatin Cellular Pharmacodynamics
by: Ardith W. El-Kareh, et al.
Published: (2003-03-01)

Successful treatment of renal malakoplakia via the reduction of immunosuppression and antimicrobial therapy after kidney transplantation: a case report
by: Seung Hyuk Yim, et al.
Published: (2022-12-01)

A Systematic Review of Adherence to Immunosuppression among Pediatric Heart Transplant Patients
by: Keira Nassetta, et al.
Published: (2022-05-01)

Graft outcomes following immunosuppressive therapy with different combinations in kidney transplant recipients: a nationwide cohort study
by: Tsai YF, et al.
Published: (2018-06-01)

Clinical characteristics and immunosuppression management in kidney transplant recipients infected with severe acute respiratory syndrome coronavirus 2 infection - An observational study
by: Kiruthika Somasundaram, et al.
Published: (2022-01-01)

Robert S. Schwartz, MD, a transformative figure in immunosuppression that revolutionized transplantation
by: Xian C. Li
Published: (2023-08-01)

Two-Mechanism Peak Concentration Model for Cellular Pharmacodynamics of Doxorubicin
by: Ardith W. El-Kareh, et al.
Published: (2005-07-01)

Torque Teno Virus Load Predicts Opportunistic Infections after Kidney Transplantation but Is Not Associated with Maintenance Immunosuppression Exposure
by: Lucía Cañamero, et al.
Published: (2023-05-01)

In vitro co-culture systems of hepatic and intestinal cells for cellular pharmacokinetic and pharmacodynamic studies of capecitabine against colorectal cancer
by: Chun Ge, et al.
Published: (2023-01-01)

Targeted Urine Metabolomics for Monitoring Renal Allograft Injury and Immunosuppression in Pediatric Patients
by: Tara K. Sigdel, et al.
Published: (2020-07-01)

Efficacy and safety of basiliximab as initial immunosuppression in liver transplantation: A single center study
by: Mohamed Hashim, et al.
Published: (2020-09-01)

A Polyclonal Immune Function Assay Allows Dose-Dependent Characterization of Immunosuppressive Drug Effects but Has Limited Clinical Utility for Predicting Infection on an Individual Basis
by: Stefanie Marx, et al.
Published: (2020-05-01)

REPEAT KIDNEY TRANSPLANTATION
by: A. I. Sushkov
Published: (2017-01-01)

Induction Strategies in Lung Transplantation: Alemtuzumab vs. Basiliximab a Single-Center Experience
by: Masashi Furukawa, et al.
Published: (2022-06-01)

Comparison of clinical outcomes of deceased donor kidney transplantations, with a focus on three induction therapies
by: Eun Sung Jeong, et al.
Published: (2019-12-01)

Graft-derived cell-free DNA as a rejection biomarker and a monitoring tool for immunosuppression in liver transplantation
by: V U Lakshmi, et al.
Published: (2023-01-01)

Immunosuppression status of liver transplant recipients with hepatitis C affects biopsy-proven acute rejection
by: Jong Man Kim, et al.
Published: (2016-09-01)

Preventing Rejection of the Kidney Transplant
by: Divyanshu Malhotra, et al.
Published: (2023-09-01)

A systematic review and meta-analysis comparing everolimus and calcineurin inhibitors (CNIs) to mycophenolate and CNIs in kidney transplant patients
by: Larraine Vergara-Rejante, et al.
Published: (2023-03-01)

Managament of Immunosuppression in Kidney Post Transplantation
by: R. Formica, et al.
Published: (2006-08-01)

Immunosuppressive Therapy Protocols in Kidney Transplantation in Adults
by: Jasenko Karamehić, et al.
Published: (2006-08-01)

A strategy for designing voriconazole dosage regimens to prevent invasive pulmonary aspergillosis based on a cellular pharmacokinetics/pharmacodynamics model
by: Taotao Wang, et al.
Published: (2018-06-01)

Circular RNA MAP2K2‐modified immunosuppressive dendritic cells for preventing alloimmune rejection in organ transplantation
by: Shuailong Li, et al.
Published: (2024-01-01)

Patient-reported non-adherence and immunosuppressant trough levels are associated with rejection after renal transplantation
by: Jennifer Scheel, et al.
Published: (2017-03-01)

Immunosuppressive cells in cancer: mechanisms and potential therapeutic targets
by: Yan Tie, et al.
Published: (2022-05-01)

Immunologic strategies and outcomes in ABO-incompatible living donor liver transplantation
by: Jongwook Oh, et al.
Published: (2020-01-01)

Kidney allograft rejection and coronavirus disease 2019 infection: A narrative review
by: Seyed Amirhossein Fazeli, et al.
Published: (2023-01-01)

BK Polyomavirus Nephropathy in Kidney Transplantation: Balancing Rejection and Infection
by: Chia-Lin Shen, et al.
Published: (2021-03-01)

A comparison of efficiency and safety between dual and triple immunosuppressive regimens in pediatric living donor liver transplantation at King Chulalongkorn Memorial Hospital
by: Athaya Vorasittha, et al.
Published: (2021-12-01)